Aspen signs MOU for TB products
Johannesburg – JSE listed Aspen (APN) and Indian based Lupin Limited have entered into a Memorandum of Understanding for the establishment of a 50:50 joint
Aspen and BMS conclude strategic ARV deal
JSE listed Aspen Pharmacare Holdings Limited, Africa’s largest pharmaceutical manufacturer and the largest generic manufacturer in the southern hemisphere, has signed a non-exclusive license and
Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs
Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs Agreements with Nine Companies Will Lower Prices of HIV
Aspen and Lupin sign TB deal
JSE listed Aspen Pharmacare Holdings Limited and Lupin Limited of India have entered into an agreement to collaborate in the tuberculosis (TB) related products market
Aspen and India’s Matrix sign JVs
Aspen Pharmacare Holdings Limited (Aspen) has signed definitive joint venture (JV) agreements with Indian-based Matrix Laboratories Limited (Matrix). The deals strengthen Aspen’s vertical integration into
Transactions
Aspen manufactures Africa’s first generic ARVs
Pretoria – Aspen Pharmacare, Southern Africa’s largest generics manufacturer and JSE Securities Exchange listed pharmaceutical company, has announced the launch of Aspen-Stavudine – the first
Transactions
Boehringer Ingelheim grants a voluntary license for nevirapine to South African company Aspen Pharmacare
South Africa – Boehringer Ingelheim South Africa announced today that it has granted a voluntary license to the South African pharmaceutical manufacturer Aspen Pharmacare for
World-Class Oral Contraceptive Facility opened
East London – Bevan Gogwana, MEC for health in the Eastern Cape officially opened Aspen Pharmacare’s Oral Contraceptive manufacturing facility earlier today. Stephen Saad, Group
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
